GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (STU:HBI) » Definitions » Book to Bill Ratio

Harvard Bioscience (STU:HBI) Book to Bill Ratio : 0.00 (As of . 20)


View and export this data going back to 2014. Start your Free Trial

What is Harvard Bioscience Book to Bill Ratio?

Book to Bill Ratio is the ratio of orders received to units billed for a specified period.

The historical rank and industry rank for Harvard Bioscience's Book to Bill Ratio or its related term are showing as below:

STU:HBI's Book to Bill Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median:
* Ranked among companies with meaningful Book to Bill Ratio only.

Harvard Bioscience Book to Bill Ratio Historical Data

The historical data trend for Harvard Bioscience's Book to Bill Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Bioscience Book to Bill Ratio Chart


Harvard Bioscience  (STU:HBI) Book to Bill Ratio Calculation

Book to Bill Ratio is calculated as

Book to Bill Ratio=Orders Received / Orders Shipped

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harvard Bioscience  (STU:HBI) Book to Bill Ratio Explanation

The book-to-bill ratio is the ratio of orders received to units shipped and billed for a specified period, generally a month or quarter. It is a widely used metric in the technology industry, specifically in the semiconductor equipment sector. The book-to-bill ratio reveals how quickly a business fulfills the demand for its products.

Investors and analysts closely watch this ratio for an indication of the performance and outlook for individual companies and the technology sector as a whole. A ratio above 1.0 implies more orders were received than filled, indicating strong demand, while a ratio below 1.0 implies weaker demand.

Harvard Bioscience Book to Bill Ratio Related Terms

Thank you for viewing the detailed overview of Harvard Bioscience's Book to Bill Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Harvard Bioscience (STU:HBI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (STU:HBI) » Definitions » Book to Bill Ratio
Comparable Companies
INFU YBGJ STXS KRMD AKYA BNGO PDEX MLSS DXR UEEC ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD OCSE:COLO B TSE:4543 WST XSWX:STMN
Traded in Other Exchanges
HBIO:USA
Address
84 October Hill Road, Holliston, MA, USA, 01746
Website
https://www.harvardbioscience.com
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.